Designed to support the generation of LAK cells in a serum-free environment
The original protocols involved the incubation of patient or normal donor peripheral blood lymphocytes (PBL) at 1.0 - 3.0 x 106 cells/mL for a period of 3 days in the presence of 1000 Cetus units of rIL-2/mL
Contains L-glutamine, gentamicin, and phenol red
Clinical proven formulations providing process safety and constancy
High productivity resulting in a high viable cell yield
Superior media for most hematopoietic cells types including dendritic cells, lymphocytes, monocytes, macrophages and granulocytes.
Formulations only contain human derived components
More regulatory friendly as human component is replaced by a recombinant one
Highly cited in scientific literature
Clinical proven formulations providing process safety and constancy
High productivity resulting in a high viable cell yield
Serum Free media result in a more defined process and result in limited immune response
Efficient transgene expression Desirable T-cell phenotype